Coagulation/Hemostasis Analyzer Market

Coagulation/Hemostasis Analyzer Market Size (2022 to 2027)

The global coagulation/hemostasis analyzer market size is expected to be worth USD 4.84 billion by 2027, growing at a CAGR of 10.2% during the forecast period.

These analyzers are very much helpful in examining the hemostasis system in laboratories. Coagulometers are used in various methods, such as to observe blood clots in the blood. Coagulation analyzers follow easy steps to measure blood platelet levels. The early diagnosis of the hemostasis system can prevent blood clots which might cause heart attacks. Most importantly, coagulation analyzers can evaluate the thromboline and thromboplastin concentrations in very little time. Also, these analyzers are user-friendly as they can evaluate the required measurement in a few minutes, which helps prevent bleeding to blood clots.

MARKET DRIVERS:

The major factor driving the growth of the global coagulation/hemostasis analyzer market is the rising number of cardiovascular problems worldwide.

Changes in lifestyles and increasing obesity cases due to changes in food habits are also some common factors propelling the growth rate of the coagulation/hemostasis market. In addition, creating awareness over the availability of diagnostics procedures that can prevent heart attacks is enhancing the demand of this market. A growing number of people suffering from blood disorders is accelerating the market's growth rate to the extent.

Focus on developing innovative techniques and the rise in the number of research centers in the biotechnology field is to create growth opportunities for the coagulation/hemostasis analyzers market. The increasing prevalence of automation equipment in laboratories is greatly influencing the demand of the market eventually. The growing geriatric population is also one of the factors gearing up the growth rate of the market. Constant economic growth in both developed and developing countries is lucratively surging the demand of the market. Increasing investments in healthcare by private and public organizations are also impacting the market's demand towards positive.

MARKET RESTRAINTS:

Lack of standardization is slowly hindering the growth rate of the global coagulation/hemostasis analyzer market.

Automatic coagulation analyzers require huge amounts for installation and maintenance, which is remained a challenging factor for the market developers. Strict rules and regulations by government organizations in approving medical equipment also impede the growth rate of the coagulation/hemostasis analyzers market. The availability of alternative devices that are highly advanced at a lower price is quietly limiting the market demand. People in rural areas are less aware of these techniques due to a lack of proper knowledge in the analyzers' utilization, which is degrading the growth rate of the market.

REPORT COVERAGE:

This research report on the global coagulation/hemostasis analyzer market has been segmented and sub-segmented into the following categories.

Coagulation/Hemostasis Analyzer Market - By Test:

• ACT
• APTT
• D Dimer Testing
• Platelet Function Test
• Prothrombin Time Testing
• Anti-Factor XA Test
• Heparin
• Protamine Dose-Response Test For ACT
• Fibrinogen Testing
• Other Coagulation Tests

Based on tests, prothrombin time testing has the largest market share in this segment. It is also the fastest-growing due to the increasing automation of this process in laboratories.

Coagulation/Hemostasis Analyzer Market - By Product:

• POC Testing Analyzers
• Clinical Laboratory Analyzers

Based on product, Clinical laboratory analyzers have the largest market in this segment.

Coagulation/Hemostasis Analyzer Market - By End Users:

• Clinical Laboratories
• PoC

Based on end-users, Clinical laboratories have the largest share in the segment.

Coagulation/Hemostasis Analyzer Market - By Technology:

• Electrochemical
• Optical
• Mechanical

Based on technology, the Optical segment has the largest market share and is also the fastest-growing segment.

Coagulation/Hemostasis Analyzer Market - By Region:

• North America
• Europe
• Asia-pacific
• Latin America
• The Middle East and Africa

Geographically, the North American Market is expected to hold the largest share in the global market and had accounted for a 35.0% share in the global market during the forecast period. Factors such as an increase in lifestyle diseases such as obesity, diabetes, cardiovascular disorders, and the growing repetition of blood disorders are significant factors driving the North American market. In North America, the U.S. market is forecasted to lead during the forecast period, followed by Canada.

The European Market is expected to be the second-largest market in the global coagulation/hemostasis analyzer market during the forecast period. The factors driving the European market in the European region are the growing aging population, Y-O-Y growth in the incidence rate of chronic blood diseases, inactive lifestyle changes, and rising blood relevant disorders. The German market is predicted to dominate the European market during the forecast period.

The Asia-Pacific market is predicted to be the fastest-growing region in the global coagulation/hemostasis analyzer market. As a result of advancements in healthcare infrastructure in countries like China, Japan, and India, a growing number of general surgeries and an increasing number of research activities occur in few countries of the APAC region. China is predicted to showcase potentiality to grow with 12.7% in the forthcoming years.

The Latin American market is projected to perform well during the forecast period. Factors such as the growing number of people suffering from chronic blood disorders, an increasing number of hospitals and healthcare centers in Latin American are expected to boost the Latin American market growth. Moreover, growing investments in R&D activities, rising awareness among people regarding the advanced technologies further foster the Latin American hemostasis analyzer market. In Latin America, the Brazilian market is expected to play the leading role during the forecast period.

The Middle East & Africa Market is expected to have a sluggish growth rate during the forecast period.

KEY MARKET PLAYERS:

Some of the notable participants dominating the Global Coagulation/Hemostasis Analyzer Market Profiled in the Report are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), International Technidyne Corporation (U.S.), Nihon Kohden Corporation (Japan) and Diagnostica Stago (France).

RECENT MARKET DEVELOPMENTS:

• In December 2018, Sysmex, a well-known blood clotting company, announced introducing automated blood coagulation analyzers CN-6000 and CN-3000. This announcement will boost up the position of the company.
• In April 2018, Sysmex CS-2500 systems offered the specific capacity to the test outcomes in the laboratories. Sysmex CS-2500 system is introduced by Siemens Healthineers Laboratory Diagnostics and allows using PSI technologies by mid-volume laboratories.